Top Markets
#1 Islamic Coin Islamic Coin +152.61%
#2 Bitway Bitway +56.67%
#3 Wrapped STX (Velar) Wrapped STX (Velar) +38.37%
#4 Starpower Starpower +38.35%
#5 Pons Pons +36.57%
#6 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +26.29%
#7 aelf aelf +23.64%
#8 SkyAI SkyAI +20.62%
#9 Ocean Protocol Ocean Protocol +18.23%
#10 Decred Decred +14.92%
Coin of the day
Islamic Coin Islamic Coin
Settings
Language
ENGLISH
Currency
USD
Theme
BCWORLD PHARM. Co., Ltd. BCWORLD PHARM. Co., Ltd.

BCWORLD PHARM. Co., Ltd.

200780
Rank in Stocks #29377
BCWORLD PHARM. Co., Ltd. operates as a pharmaceutical enterprise in South... BCWORLD PHARM. Co., Ltd. operates as a pharmaceutical enterprise in South Korea, providing a comprehensive range of medical solutions. Its extensive product portfolio addresses diverse therapeutic areas, including the musculoskeletal system, digestive health, cardiovascular disorders, and central nervous system conditions. The company also supplies adrenocorticosteroids, narcotic analgesics, erectile dysfunction therapies, wellness injections, diuretics, antitussive expectorants, vaginitis treatments, anti-tuberculosis medications, anti-emetics, antiviral and antibiotic drugs, anti-malignant tumor agents, antifungal agents, antihistamines, antidotes, and antipyretic, analgesic, and anti-inflammatory compounds. Established in 1980, the firm maintains its headquarters in Seongnam-si, South Korea.
Share Price
$2.10
Market Cap
$21.45M
Change (1 day)
-2.10%
Change (1 year)
-32.36%
Country
KR
Trade BCWORLD PHARM. Co., Ltd. (200780)

Category

Healthcare
Revenue for BCWORLD PHARM. Co., Ltd. (200780)
Revenue in Aug 2026 TTM: 0
According to BCWORLD PHARM. Co., Ltd. latest financial reports the company's current revenue (TTM) is 0. In 2026 the company made a revenue of 0 equal to the revenue in the year 2026 that was 0. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for BCWORLD PHARM. Co., Ltd. from 2026 to 2026
Revenue at the end of each year
Year Revenue Change
Not enough data for the provided dates.
Revenue for similar companies or competitors
Company Revenue Revenue Difference Country
Eli Lilly and Company Eli Lilly and Company
Eli Lilly and Company
LLY.US
 $79.67B -
US
Johnson & Johnson Johnson & Johnson
Johnson & Johnson
JNJ.US
 $97.93B -
US
AbbVie Inc. AbbVie Inc.
AbbVie Inc.
ABBV.US
 $64.39B -
US
Roche Holding AG Roche Holding AG
Roche Holding AG
RO.SW
 $77.52B -
CH
Merck & Co., Inc. Merck & Co., Inc.
Merck & Co., Inc.
MRK.US
 $66.40B -
US